🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge
Demo corpus. Scores are computed on a select set of biomedical paper/datasets and may be inaccurate for papers outside this corpus — DataRank relies on network effects that improve with scale. We aim to expand this into a fully open resource pending additional funding.

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

Advances in Enzyme Regulation(1984)10.1016/0065-2571(84)90007-4Source: DataRank Database

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors is a research paper published in Advances in Enzyme Regulation (1984). On theSindex it has a DataRank of 1.3. It has been cited 7,149 times.

N/A
1.3DataRank · unranked
1.3
7149 citations · base score 8.9
Cite:
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Abstract

A generalized method for analyzing the effects of multiple drugs and for determining summation, synergism and antagonism has been proposed. The derived, generalized equations are based on kinetic principles. The method is relatively simple and is not limited by whether the dose-effect relationships are hyperbolic or sigmoidal, whether the effects of the drugs are mutually exclusive or nonexclusive, whether the ligand interactions are competitive, noncompetitive or uncompetitive, whether the drugs are agonists or antagonists, or the number of drugs involved. The equations for the two most widely used methods for analyzing synergism, antagonism and summation of effects of multiple drugs, the isobologram and fractional product concepts, have been derived and been shown to have limitations in their applications. These two methods cannot be used indiscriminately. The equations underlying these two methods can be derived from a more generalized equation previously developed by us (59). It can be shown that the isobologram is valid only for drugs whose effects are mutually exclusive, whereas the fractional product method is valid only for mutually nonexclusive drugs which have hyperbolic dose-effect curves. Furthermore, in the isobol method, it is laborious to find proper combinations of drugs that would produce an iso-effective curve, and the fractional product method tends to give indication of synergism, since it underestimates the summation of the effect of mutually nonexclusive drugs that have sigmoidal dose-effect curves. The method described herein is devoid of these deficiencies and limitations. The simplified experimental design proposed for multiple drug-effect analysis has the following advantages: It provides a simple diagnostic plot (i.e., the median-effect plot) for evaluating the applicability of the data, and provides parameters that can be directly used to obtain a general equation for the dose-effect relation; the analysis which involves logarithmic conversion and linear regression can be readily carried out with a simple programmable electronic calculator and does not require special graph paper or tables; and the simplicity of the equation allows flexibility of application and the use of a minimum number of data points. This method has been used to analyze experimental data obtained from enzymatic, cellular and animal systems.

Data sources & pipeline
Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring
Enrichment:Pending

FAIR Checklist

Context only (not used in score)
Findable (1/2)
  • Has DOI
Accessible (0/2)
    Interoperable (0/2)
      Reusable (0/3)

        FAIR checklist signals are shown for context only and do not affect DataRank scoring.

        DataRank Breakdown

        Base Score 100%Citation Network 0%

        Base Score Contribution

        1.3

        From this paper's citation signal

        Citation Network Contribution

        0

        Citation network not refreshed for this result

        This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

        Learn more about DataRank methodology →
        Why this DataRank?

        DataRank blends this paper's own citation count with the influence of the papers that cite it. Here, roughly 100% comes from its base citations and 0% from the citation network.

        Base score B(p)
        log1p(citation_count) — grows sub-linearly, so a paper with 1,000 citations is not 10× a paper with 100.
        Network N(p)
        Σ over citers of log1p(Cq) ÷ max(outdegreeq, 1). Being cited by a highly-cited paper with few references counts most.
        Damping factor d = 0.85
        DataRank = (1−d)·B(p) + d·N(p) — the two cards above are each already multiplied by their share.
        Self-citations excluded
        Citers sharing any OpenAlex author ID with this paper are filtered out before the network sum.

        Citers are pulled from OpenAlex sorted by cited_by_count:descand capped per paper, so when the cap binds we keep the highest-signal references and the score is reproducible across reruns.

        Read the full methodology →

        Authors (3)

        Paul Talalay,Ting‐Chao ChouORCID,Ting-Chao Chou

        Related Papers (4)

        Journal of Economic Entomology(1925)
        co-cited
        10.1093/jee/18.2.265a
        New England Journal of Medicine(2011)
        co-cited
        10.1056/nejmoa1011923